Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 June 2023 | Story Sfundo Mazibuko | Photo Supplied
Sfundo Mazibuko
Sfundo Mazibuko is a Presidential Youth Employment Initiative (PYEI) Intern in the Qwaqwa Campus Health and Wellness Centre

The University of the Free State (UFS) is celebrating Youth Month by showcasing the positive influence of the institution on career development. As part of this initiative, we are sharing the stories of UFS alumni who are now working at the university.

Sfundo Mazibuko, Presidential Youth Employment Initiative (PYEI) Intern in the Qwaqwa Campus Health and Wellness Centre, shares his UFS journey:

Q: Year of graduation from the UFS:

A: My graduation year is 2023.

Q: Qualification obtained from the UFS:

A: Bachelor of Education in Intermediate Phase Teaching, majoring in social sciences and life skills.

Q: Date of joining the UFS as a staff member:

A: March 2023.

Q: Initial job title and current job title:

A: Data Capture Intern in the Health and Wellness Centre.

Q: How did the UFS prepare you for the professional world? 

A: Since I started working as a UFS staff member, I have gained skills in collaborating with colleagues, administration skills, data capturing skills, client welcoming skills, confidentiality skills, and time management skills.

Q: What are your thoughts on transitioning from a UFS alumnus to a staff member?

A: Working at the UFS is an incredibly rewarding experience, with ample career advancement opportunities, a focus on work-life balance, comprehensive benefits, a collaborative work culture, and a commitment to making a positive impact. The UFS nurtures its employees' growth through professional development programmes, offers flexible work arrangements, provides competitive perks, fosters inclusivity and teamwork, and actively engages in philanthropic initiatives. Joining the UFS means embarking on a fulfilling journey of personal and professional growth.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept